Wei Yuan1, Zhou Zhang1,2, Binghua Dai3, Qing Wei4, Jinjin Liu5, Yuzhen Liu6, Yun Liu7, Lin He1,7,8, Daizhan Zhou1,8. 1. Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China. 2. Institute of Biliary Tract Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 3. The Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China. 4. Department of Pathology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China. 5. Zhengzhou Translational Medicine Research Center, Zhengzhou Sixth People's Hospital, Zhengzhou, Henan Province, China. 6. Department of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, China. 7. Institute of Biomedical Sciences, Fudan University, Shanghai, China. 8. Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract
BACKGROUND: Genomic alterations of small bowel cancers remain poorly understood due to the rarity of these diseases. In the current study, the authors report the identification of somatic mutations from patients with duodenal adenocarcinoma by whole-exome sequencing. METHODS: Whole-exome sequencing and follow-up analysis were conducted in 12 matched tumor-normal tissue duodenal adenocarcinoma tissue pairs to examine the genetic characteristics of this disease. Somatic mutations (single-nucleotide variants and short insertion/deletions) were obtained and filtered and then searched for recurrently mutated genes and pathways. RESULTS: An excess of C-to-T transitions at the CpG dinucleotide was observed in the substitution of bases. The authors identified recurrent mutations in tumor protein p53 (TP53), KRAS, catenin (cadherin-associated protein) β-1 (CTNNB1), AT-rich interactive domain 2 (ARID2), adenomatous polyposis coli (APC), erb-b2 receptor tyrosine kinase 2 (ERBB2), ARID1A, cadherin-related family member 1 (CDHR1), NRAS, Bcl-2-related ovarian killer (BOK), radial spoke head 14 homolog (chlamydomonas) (RTDR1), cell division cycle 27 (CDC27), catalytic subunit of phosphoinositide-3-kinase (PIK3CA), and SMAD family member 4 (SMAD4). Pathway scan indicated that the Wnt signaling pathway, regulation of the actin cytoskeleton pathway, ErbB signaling pathway, and the pathway of focal adhesion were the most extensively affected pathways. CONCLUSIONS: This genomic characterization of duodenal adenocarcinoma provides researchers with insight into its somatic landscape and highlights the vital role of the Wnt/β-catenin signaling pathway. The study data also indicate that duodenal adenocarcinomas have a genetic resemblance to gastric and colorectal cancers. These discoveries may benefit the future development of molecular diagnosis and personalized therapies. Cancer 2016;122:1689-96.
BACKGROUND: Genomic alterations of small bowel cancers remain poorly understood due to the rarity of these diseases. In the current study, the authors report the identification of somatic mutations from patients with duodenal adenocarcinoma by whole-exome sequencing. METHODS: Whole-exome sequencing and follow-up analysis were conducted in 12 matched tumor-normal tissue duodenal adenocarcinoma tissue pairs to examine the genetic characteristics of this disease. Somatic mutations (single-nucleotide variants and short insertion/deletions) were obtained and filtered and then searched for recurrently mutated genes and pathways. RESULTS: An excess of C-to-T transitions at the CpG dinucleotide was observed in the substitution of bases. The authors identified recurrent mutations in tumor protein p53 (TP53), KRAS, catenin (cadherin-associated protein) β-1 (CTNNB1), AT-rich interactive domain 2 (ARID2), adenomatous polyposis coli (APC), erb-b2 receptor tyrosine kinase 2 (ERBB2), ARID1A, cadherin-related family member 1 (CDHR1), NRAS, Bcl-2-related ovarian killer (BOK), radial spoke head 14 homolog (chlamydomonas) (RTDR1), cell division cycle 27 (CDC27), catalytic subunit of phosphoinositide-3-kinase (PIK3CA), and SMAD family member 4 (SMAD4). Pathway scan indicated that the Wnt signaling pathway, regulation of the actin cytoskeleton pathway, ErbB signaling pathway, and the pathway of focal adhesion were the most extensively affected pathways. CONCLUSIONS: This genomic characterization of duodenal adenocarcinoma provides researchers with insight into its somatic landscape and highlights the vital role of the Wnt/β-catenin signaling pathway. The study data also indicate that duodenal adenocarcinomas have a genetic resemblance to gastric and colorectal cancers. These discoveries may benefit the future development of molecular diagnosis and personalized therapies. Cancer 2016;122:1689-96.
Authors: Liana Adam; F Anthony San Lucas; Richard Fowler; Yao Yu; Wenhui Wu; Yulun Liu; Huamin Wang; David Menter; Michael T Tetzlaff; Joe Ensor; Ganiraju Manyam; Stefan T Arold; Chad Huff; Scott Kopetz; Paul Scheet; Michael J Overman Journal: Clin Cancer Res Date: 2018-10-23 Impact factor: 12.531
Authors: Alexa B Schrock; Craig E Devoe; Robert McWilliams; James Sun; Thomas Aparicio; Philip J Stephens; Jeffrey S Ross; Richard Wilson; Vincent A Miller; Siraj M Ali; Michael J Overman Journal: JAMA Oncol Date: 2017-11-01 Impact factor: 31.777
Authors: Ulrika A Hänninen; Riku Katainen; Tomas Tanskanen; Roosa-Maria Plaketti; Riku Laine; Jiri Hamberg; Ari Ristimäki; Eero Pukkala; Minna Taipale; Jukka-Pekka Mecklin; Linda M Forsström; Esa Pitkänen; Kimmo Palin; Niko Välimäki; Netta Mäkinen; Lauri A Aaltonen Journal: PLoS Genet Date: 2018-03-09 Impact factor: 5.917
Authors: A Quaas; D Waldschmidt; H Alakus; T Zander; C Heydt; T Goeser; M Daheim; P Kasper; P Plum; C Bruns; A Brunn; W Roth; N Hartmann; A Bunck; M Schmidt; H Göbel; L Tharun; R Buettner; S Merkelbach-Bruse Journal: BMC Gastroenterol Date: 2018-05-31 Impact factor: 3.067